Heterozygous or de novo mutations in the dnm1l gene, coding for DRP1 protein, have been shown to cause microcephaly, optic atrophy, hypoplasia, epileptic encephalopathy, and neurodevelopment delay [79,80,81]. Here, DNM1L is linked to Epileptic encephalopathy.